Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial
about
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Carboplatin versus two doses o ...... oup randomised phase III trial
@en
type
label
Carboplatin versus two doses o ...... oup randomised phase III trial
@en
prefLabel
Carboplatin versus two doses o ...... oup randomised phase III trial
@en
P2093
P2860
P50
P1476
Carboplatin versus two doses o ...... oup randomised phase III trial
@en
P2093
A D Chetiyawardana
Barbara Crosse
Conrad Lewanski
D Muthukumar
David Dunlop
David Ferry
Geraldine Skailes
Hugh Jarrett
Joyce Thompson
Kenneth O'Byrne
P2860
P304
P356
10.1016/J.EJCA.2017.05.037
P577
2017-08-04T00:00:00Z